Tillman Gerngross makes it official: He's out as CEO as troubled Adagio vows to soldier on
The other shoe has dropped at Adagio.
On Wednesday evening, the company put out a release saying that founding CEO Tillman Gerngross, a high profile figure in the antibody world, had resigned — confirming an earlier SEC filing that he had agreed to leave. In his place, the board appointed COO David Hering to the interim CEO job, while launching a search for a new chief.
The board went on to praise Gerngross for creating a strong foundation at the company, which includes a cushion of cash after raising more than $800 million in a little more than a year while taking the company public $ADGI.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.